Form 8-K - Current report:
SEC Accession No. 0000950135-06-004205
Filing Date
2006-07-06
Accepted
2006-07-06 12:02:26
Documents
5
Period of Report
2006-06-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 OXIGENE, INC. b61505oie8vk.htm 8-K 24507
2 EX-10.1 DR. CHIN EMPLOYMENT AGREEMENT, DATED 6/29/06 b61505oiexv10w1.htm EX-10.1 79394
3 EX-10.2 MR. DRISCOLL SEPARATION AGREEMENT, DATED 6/29/06 b61505oiexv10w2.htm EX-10.2 33564
4 EX-99.1 PRESS RELEASE, DATED 6/30/06 b61505oiexv99w1.htm EX-99.1 9618
5 GRAPHIC b61505oib6150501.gif GRAPHIC 3928
  Complete submission text file 0000950135-06-004205.txt   154180
Mailing Address
Business Address 321 ARSENAL STREET WATERTOWN MA 02472 6176737800
OXIGENE INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21990 | Film No.: 06946962
SIC: 2836 Biological Products, (No Diagnostic Substances)